Total Reports
222
Above-median volume
Breed profile · FDA CVM July 2026 extract
Adverse-event filings for Spaniel - Tibetan (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.
By recorded gender -- every report on file for Spaniel - Tibetan, no filtering.
Data updated September 2026
The verdict
According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Spaniel - Tibetan ranks #182 of 510 by total reports (222) and #130 of 275 by death-coded share (5.0%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).
Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.
Release-over-release change
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Spaniel - Tibetan has 222 reports now versus 221 in that prior snapshot: 1 more (0.5%).
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Spaniel - Tibetan changesTotal Reports
222
Above-median volume
Deaths Reported
11
of 222 reports
Death-coded share of reports
5.0%
Above-median death-coded share
Avg Age at Report
7.2 yr
7.8 kg avg weight
A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.
Share of reports coded as a fatality
Share of reports resulting in euthanasia
Share of reports coded "Recovered/Normal"
Change in annual report volume over the last 5 complete years
5.0% of 222 spaniel - tibetan reports involved a death outcome.
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
| Year | Reports | Trend |
|---|---|---|
| 2010 | 12 | |
| 2011 | 12 | |
| 2012 | 17 | |
| 2013 | 17 | |
| 2014 | 20 | |
| 2015 | 20 | |
| 2016 | 14 | |
| 2017 | 23 | |
| 2018 | 8 | |
| 2019 | 9 | |
| 2020 | 13 | |
| 2021 | 11 | |
| 2022 | 12 | |
| 2023 | 11 | |
| 2024 | 11 | |
| 2025 | 12 | |
Signature read: mid-pack filing volume at 222 (#182 of 510) is the scale stamp on Spaniel - Tibetan. According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Spaniel - Tibetan sits at #182 of 510 by report volume among all breeds and #144 of 298 among dog breeds, with 222 reports and 11 (5.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #130 of 275. Mean age at report: 7.2 years, average weight 7.8 kg (17.2 lbs).
Top reported signs: Vomiting (55), Lethargy (see also Central nervous system depression in 'Neurological') (29), Emesis (21). Most-referenced drug: Milbemycin Oxime + Spinosad (47 reports), followed by Spinosad (21) and Pyrantel Pamoate;Sarolaner (18).
Outcome coding on 201 status-recorded reports is dominated by Recovered/Normal (43.3%). Annual submissions ranged 8-2,025 across 16 years on file.
Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.
Two openFDA-derived peer sets for Spaniel - Tibetan, both outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).
Nearest other-species breeds with ≥50 reports (5.0% death-coded here).
Nearest other-species breeds by reported average weight (7.8 kg here).
What to do with this dog
A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →